Long‐Term Outcome and Treatment Modifications in a Prospective Cohort of Human Immunodeficiency Virus Type 1–Infected Patients on Triple‐Drug Antiretroviral Regimens
Open Access
- 1 October 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (4) , 987-994
- https://doi.org/10.1086/318154
Abstract
We designed a cohort in order to assess the long-term effects of triple-drug antiretroviral combinations in 608 patients infected with human immunodeKeywords
This publication has 17 references indexed in Scilit:
- The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997AIDS, 1999
- Combination Antiretroviral Therapy and Recent Declines in AIDS Incidence and MortalityThe Journal of Infectious Diseases, 1999
- Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapiesAIDS, 1999
- The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infectionAIDS, 1999
- Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patientsAIDS, 1998
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997